Inactive Instrument

Calendar Veru Inc Nasdaq

Equities

US3144621022

Chart calendar Veru Inc

ee23b6.BQdc4BpmtOh7KHQNmfJp1Ls8vsl89iTEyvXpIi5x-Z0.UV0bq1Yt55FPECtZ3YsFrt9p7vAthVCH_5SHdE8JnuxHdh2xay6A2z5pEw~4ca0b4c902bed2450dc1111a50944038

Upcoming events on Veru Inc

2024-05-08 Q2 2024 Earnings Release (Projected)
2024-05-08 09:45 pm American Association of Clinical Endocrinology Conference
2024-05-09 03:30 pm American Association of Clinical Endocrinology Conference
2024-06-17 Annual General Meeting
2024-08-07 Q3 2024 Earnings Release (Projected)
2025-02-04 Q1 2025 Earnings Release (Projected)
2026-02-10 Q1 2026 Earnings Release (Projected)

Past events on Veru Inc

2024-02-14 12:40 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-08 08:00 am Q1 2024 Earnings Call
2024-02-08 06:30 am Q1 2024 Earnings Release
2024-01-04 08:00 am Business Update Call
2023-09-28 10:55 am Cantor Global Healthcare Conference
2023-09-11 09:00 am H.C. Wainwright Global Investment Conference
2023-08-10 08:00 am Q3 2023 Earnings Call
2023-08-10 06:30 am Q3 2023 Earnings Release
2023-07-24 09:00 am Extraordinary Shareholders Meeting
2023-06-07 11:00 am Jefferies Global Healthcare Conference
2023-05-11 08:00 am Q2 2023 Earnings Call
2023-05-11 06:30 am Q2 2023 Earnings Release
2023-03-28 09:00 am Annual General Meeting
2023-03-14 12:00 pm Oppenheimer Healthcare Conference
2023-02-09 08:00 am Q1 2023 Earnings Call
2023-02-09 06:30 am Q1 2023 Earnings Release
2022-12-05 08:00 am FY 2022 Earnings Call
2022-12-05 06:30 am FY 2022 Earnings Release
2022-09-27 Cantor Oncology, Hematology & HemeOnc Conference
2022-09-12 07:00 am H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodSeptember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
31,8
32,3
-1.41%
42,6
41,4
2.81%
61,3
67,5
-9.18%
39,4
48,3
-18.59%
16,3
16,4
-0.43%

8,10

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-6,44
-7,99
19.48%
-0,65
-5,76
88.77%
-5,44
8,76
-162.1%
-83,2
-62,0
-34.17%
-93,7
-95,3
1.64%

-37,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-12,3
-12,0
-2.59%
-20,1
-10,3
-93.91%
4,27
1,60
166.54%
-83,5
-66,5
-25.69%
-92,6
-94,8
2.36%

-36,5

Net income
Million USD
Released
Forecast
Spread
-12,0
-12,1
1%
-19,0
-10,4
-83.21%
7,39
3,79
94.91%
-83,8
-66,6
-25.72%
-93,1
-94,8
1.76%

-36,5

EPS
USD
Released
Forecast
Spread
-0,19
-0,19
1.72%
-0,28
-0,16
-80.65%
0,09
0,05
80%
-1,05
-0,84
-25%
-1,10
-1,07
-3.29%

-0,26

Announcement Date12/12/1909/12/2002/12/2105/12/2208/12/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
14,1
17,3
-18.31%
13,0
15,3
-14.63%
9,60
16,7
-42.39%
2,59
11,6
-77.59%
2,51
5,07
-50.5%
6,59
4,33
52.28%
3,34
10,2
-67.32%
3,86
3,95
-2.23%
2,14
6,50
-67.07%

2,00


2,00


2,00

EBIT
Million USD
Released
Forecast
Spread
-4,96
-4,92
-0.76%
-11,8
-8,60
-36.73%
-21,8
-12,2
-78.97%
-44,7
-23,5
-90.36%
-35,6
-30,3
-17.31%
-35,5
-28,1
-26.61%
-12,6
-17,2
26.93%
-23,6
-24,0
1.58%
-7,88
-15,7
49.79%

-9,37


-9,65


-9,80

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,27
-5,51
-13.66%
-14,2
-9,23
-53.84%
-22,1
-13,2
-67.53%
-41,0
-24,1
-70.49%
-36,9
-30,6
-20.48%
-38,9
-27,4
-41.97%
6,37
-17,3
136.74%
-23,2
-24,3
4.38%
-8,35
-15,7
46.83%

-9,10


-9,39


-9,60

Net income
Million USD
Released
Forecast
Spread
-6,38
-7,99
20.15%
-14,2
-9,26
-53.13%
-22,2
-13,2
-68.57%
-41,0
-24,1
-70.54%
-36,8
-30,6
-20.26%
-38,8
-28,3
-37.18%
6,31
-17,3
136.41%
-23,8
-24,3
2.09%
-8,28
-15,7
47.29%

-9,10


-9,39


-9,60

EPS
USD
Released
Forecast
Spread
-0,08
-0,10
21.57%
-0,18
-0,12
-56.52%
-0,28
-0,16
-70.73%
-0,51
-0,30
-71.14%
-0,46
-0,38
-22.12%
-0,48
-0,33
-44.36%
0,07
-0,20
134.43%
-0,27
-0,24
-14.89%
-0,08
-0,15
46.67%

-0,06


-0,06


-0,06

Announcement Date09/02/2212/05/2211/08/2205/12/2209/02/2311/05/2310/08/2308/12/2301/04/24---

Past sector events for Veru Inc